Will pain patch blunt demand for needles?
This article was originally published in The Gray Sheet
Executive Summary
Alza's E-Trans fentanyl, needle-free, patient-controlled pain management patch receives 48-hour satisfaction rating of 80%, identical to that of patient-controlled morphine IV, according to 636-patient, 33-site study in March 17 issue of the Journal of the American Medical Association. The J&J subsidiary filed a new drug application with FDA in September and anticipates "some consultation" with CDRH prior to approval...